CN104136106A - 具有聚合涂层的多孔膜及其制备和使用方法 - Google Patents
具有聚合涂层的多孔膜及其制备和使用方法 Download PDFInfo
- Publication number
- CN104136106A CN104136106A CN201280070836.8A CN201280070836A CN104136106A CN 104136106 A CN104136106 A CN 104136106A CN 201280070836 A CN201280070836 A CN 201280070836A CN 104136106 A CN104136106 A CN 104136106A
- Authority
- CN
- China
- Prior art keywords
- perforated membrane
- biomolecule
- film
- membrane
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 232
- 238000000034 method Methods 0.000 title claims abstract description 106
- 238000000576 coating method Methods 0.000 title claims abstract description 48
- 239000011248 coating agent Substances 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims description 15
- 229920000642 polymer Polymers 0.000 claims abstract description 103
- 238000010894 electron beam technology Methods 0.000 claims abstract description 75
- 108091034057 RNA (poly(A)) Proteins 0.000 claims abstract description 43
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 43
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 42
- 238000003018 immunoassay Methods 0.000 claims abstract description 40
- 239000012472 biological sample Substances 0.000 claims abstract description 37
- 229920001220 nitrocellulos Polymers 0.000 claims description 146
- 239000000020 Nitrocellulose Substances 0.000 claims description 145
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims description 107
- 150000001875 compounds Chemical class 0.000 claims description 56
- 239000000463 material Substances 0.000 claims description 41
- -1 polypropylene Polymers 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 238000001514 detection method Methods 0.000 claims description 26
- 239000007790 solid phase Substances 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 24
- 150000002148 esters Chemical class 0.000 claims description 22
- 239000000523 sample Substances 0.000 claims description 19
- 239000000427 antigen Substances 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 17
- 108091007433 antigens Proteins 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 13
- 241001502050 Acis Species 0.000 claims description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 13
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 13
- 125000000524 functional group Chemical group 0.000 claims description 13
- 229910052710 silicon Inorganic materials 0.000 claims description 13
- 239000010703 silicon Substances 0.000 claims description 13
- 239000004094 surface-active agent Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 150000002433 hydrophilic molecules Chemical class 0.000 claims description 8
- 239000000178 monomer Substances 0.000 claims description 8
- 230000005855 radiation Effects 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 229920000728 polyester Polymers 0.000 claims description 6
- 150000003254 radicals Chemical class 0.000 claims description 6
- 230000035945 sensitivity Effects 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 5
- 239000004677 Nylon Substances 0.000 claims description 5
- 239000002033 PVDF binder Substances 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 5
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 5
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 5
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 5
- 125000000746 allylic group Chemical group 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 150000007942 carboxylates Chemical class 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 229920002301 cellulose acetate Polymers 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- RRLUJJJKORUBSJ-UHFFFAOYSA-N diazonio(isocyanato)azanide Chemical group [N-]=[N+]=NN=C=O RRLUJJJKORUBSJ-UHFFFAOYSA-N 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 150000002390 heteroarenes Chemical class 0.000 claims description 5
- 238000005984 hydrogenation reaction Methods 0.000 claims description 5
- 230000006872 improvement Effects 0.000 claims description 5
- 150000002527 isonitriles Chemical class 0.000 claims description 5
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 5
- 150000002825 nitriles Chemical class 0.000 claims description 5
- 229920001778 nylon Polymers 0.000 claims description 5
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical compound C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 claims description 5
- 150000008300 phosphoramidites Chemical class 0.000 claims description 5
- 239000004417 polycarbonate Substances 0.000 claims description 5
- 229920000515 polycarbonate Polymers 0.000 claims description 5
- 229920006267 polyester film Polymers 0.000 claims description 5
- 229920006393 polyether sulfone Polymers 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 229920000098 polyolefin Polymers 0.000 claims description 5
- 229920006380 polyphenylene oxide Polymers 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 229920002223 polystyrene Polymers 0.000 claims description 5
- 229920006264 polyurethane film Polymers 0.000 claims description 5
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 5
- 239000004627 regenerated cellulose Substances 0.000 claims description 5
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 5
- 229920002554 vinyl polymer Polymers 0.000 claims description 5
- 238000002965 ELISA Methods 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 239000011324 bead Substances 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 4
- 239000012857 radioactive material Substances 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 230000009870 specific binding Effects 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 claims description 4
- 210000000416 exudates and transudate Anatomy 0.000 claims description 3
- 238000003127 radioimmunoassay Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000007850 fluorescent dye Substances 0.000 claims description 2
- 239000003365 glass fiber Substances 0.000 claims description 2
- 239000003999 initiator Substances 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 210000002751 lymph Anatomy 0.000 claims description 2
- 210000003097 mucus Anatomy 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 150000002118 epoxides Chemical group 0.000 claims 23
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 claims 5
- JJRUAPNVLBABCN-UHFFFAOYSA-N 2-(ethenoxymethyl)oxirane Chemical compound C=COCC1CO1 JJRUAPNVLBABCN-UHFFFAOYSA-N 0.000 claims 5
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 claims 5
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 claims 5
- 230000036039 immunity Effects 0.000 claims 2
- 125000003010 ionic group Chemical group 0.000 claims 2
- 241001044369 Amphion Species 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 150000007824 aliphatic compounds Chemical class 0.000 claims 1
- 150000001491 aromatic compounds Chemical class 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 10
- 238000000338 in vitro Methods 0.000 abstract description 7
- 238000002405 diagnostic procedure Methods 0.000 abstract description 6
- 125000003636 chemical group Chemical group 0.000 abstract description 4
- 238000012123 point-of-care testing Methods 0.000 abstract description 2
- 238000002955 isolation Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 description 51
- 238000012986 modification Methods 0.000 description 51
- 238000012360 testing method Methods 0.000 description 36
- 150000002924 oxiranes Chemical group 0.000 description 24
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 21
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 21
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 21
- 238000003556 assay Methods 0.000 description 19
- 229920001213 Polysorbate 20 Polymers 0.000 description 14
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 14
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 12
- 229920002477 rna polymer Polymers 0.000 description 12
- 239000012491 analyte Substances 0.000 description 11
- 238000007385 chemical modification Methods 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 239000006184 cosolvent Substances 0.000 description 4
- 238000000914 diffusion-ordered spectroscopy Methods 0.000 description 4
- 238000004483 ATR-FTIR spectroscopy Methods 0.000 description 3
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- IWYRWIUNAVNFPE-UHFFFAOYSA-N Glycidaldehyde Chemical compound O=CC1CO1 IWYRWIUNAVNFPE-UHFFFAOYSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 208000013875 Heart injury Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 102000027450 oncoproteins Human genes 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0093—Chemical modification
- B01D67/00931—Chemical modification by introduction of specific groups after membrane formation, e.g. by grafting
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/009—After-treatment of organic or inorganic membranes with wave-energy, particle-radiation or plasma
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0093—Chemical modification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/14—Dynamic membranes
- B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
- B01D69/142—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers"
- B01D69/144—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers" containing embedded or bound biomolecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/08—Polysaccharides
- B01D71/12—Cellulose derivatives
- B01D71/20—Esters of inorganic acids, e.g. cellulose nitrate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/38—Graft polymerization
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Manufacturing & Machinery (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Microbiology (AREA)
- Plasma & Fusion (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Transplantation (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Peptides Or Proteins (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/340,052 US20130171618A1 (en) | 2011-12-29 | 2011-12-29 | Porous membranes having a polymeric coating and methods for their preparation and use |
| US13/339,960 US20130171026A1 (en) | 2011-12-29 | 2011-12-29 | Porous membranes having a polymeric coating and methods for their preparation and use |
| US13/340052 | 2011-12-29 | ||
| US13/339,996 US20130171368A1 (en) | 2011-12-29 | 2011-12-29 | Porous membranes having a polymeric coating and methods for their preparation and use |
| US13/339996 | 2011-12-29 | ||
| US13/339960 | 2011-12-29 | ||
| PCT/US2012/071693 WO2013101855A1 (fr) | 2011-12-29 | 2012-12-27 | Membranes poreuses à revêtement polymère et leurs procédés de préparation et d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104136106A true CN104136106A (zh) | 2014-11-05 |
Family
ID=48698596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280070836.8A Pending CN104136106A (zh) | 2011-12-29 | 2012-12-27 | 具有聚合涂层的多孔膜及其制备和使用方法 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2797680A4 (fr) |
| CN (1) | CN104136106A (fr) |
| WO (1) | WO2013101855A1 (fr) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104066497A (zh) * | 2011-12-30 | 2014-09-24 | 通用电气公司 | 具有亲水性涂层的多孔膜及其制备和使用方法 |
| CN105980846A (zh) * | 2014-02-21 | 2016-09-28 | 宝生物工程美国有限公司 | 包括聚(酸)膜分离基质的旋转柱及其制造和使用的方法 |
| CN106546729A (zh) * | 2016-10-18 | 2017-03-29 | 上海凯璟生物科技有限公司 | 一种去除干式免疫荧光定量法检测中血清基质效应的新工艺方法 |
| CN106622173A (zh) * | 2016-12-29 | 2017-05-10 | 珠海健帆生物科技股份有限公司 | Dna免疫吸附剂及其制备方法 |
| CN106823864A (zh) * | 2015-12-04 | 2017-06-13 | 中国科学院大连化学物理研究所 | 一种荧光介孔膜的制备方法 |
| CN107003306A (zh) * | 2014-11-20 | 2017-08-01 | 通用电气公司 | 具有聚合物接枝的多孔薄膜、其方法及用途 |
| CN109395616A (zh) * | 2018-12-10 | 2019-03-01 | 天津工业大学 | 一种核孔蛋白接枝均孔聚碳酸酯仿生蛋白传输膜及其制备方法 |
| CN109689189A (zh) * | 2016-09-09 | 2019-04-26 | 3M创新有限公司 | 官能化共聚物及其使用 |
| CN113125708A (zh) * | 2019-12-31 | 2021-07-16 | 暨南大学 | 一种基于核孔膜的微孔板及其制备方法与应用 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103399146A (zh) * | 2013-08-14 | 2013-11-20 | 山东农业大学 | 一种丙烯酰胺酶标记仿生免疫分析方法 |
| US11754563B2 (en) * | 2014-11-20 | 2023-09-12 | Global Life Sciences Solutions Operations UK Ltd | Porous membranes with a polymer grafting, methods and uses thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080200434A1 (en) * | 2006-09-14 | 2008-08-21 | Daniloff George Y | Chemical Target-Binding Compositions |
| US20110147308A1 (en) * | 2009-12-21 | 2011-06-23 | Siemens Water Technologies Corp. | Charged Porous Polymeric Membranes and Their Preparation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59107131D1 (de) * | 1990-07-10 | 1996-02-01 | Sartorius Gmbh | Poröse, nichtpartikuläre und konvektiv permeable matrix |
| US6306665B1 (en) * | 1999-10-13 | 2001-10-23 | A-Fem Medical Corporation | Covalent bonding of molecules to an activated solid phase material |
| US20050053642A1 (en) * | 2000-08-23 | 2005-03-10 | Mathias Ulbricht | Biocompatible materials |
| WO2003101611A1 (fr) * | 2002-05-31 | 2003-12-11 | Japan Envirochemicals, Ltd. | Materiau d'isolation destine a une substance perturbant les fonctions hormonales, technique de concentration et technique de nettoyage |
| WO2004026931A2 (fr) * | 2002-09-18 | 2004-04-01 | Emembrane, Inc. | Materiaux fonctionnalises et leurs procedes d'utilisation |
| US7919178B2 (en) * | 2003-03-21 | 2011-04-05 | Millipore Corporation | Spatially-controlled modified porous membrane |
| GB0420062D0 (en) * | 2004-09-09 | 2004-10-13 | Akubio Ltd | Assay methods,materials and preparations |
| BRPI0620798A2 (pt) * | 2005-12-30 | 2011-11-22 | 3M Innovative Properties Co | substratos funcionalizados |
| US20100143611A1 (en) * | 2008-12-05 | 2010-06-10 | General Electric Company | Methods for making an asymmetric composite membrane |
| DE102009057993A1 (de) * | 2009-06-13 | 2011-01-20 | Sartorius Stedim Biotech Gmbh | Polysaccharidmatrix mit aufgepfropftem Polymer, Verfahren zu ihrer Herstellung und Verwendung |
-
2012
- 2012-12-27 EP EP12863951.5A patent/EP2797680A4/fr not_active Withdrawn
- 2012-12-27 WO PCT/US2012/071693 patent/WO2013101855A1/fr active Application Filing
- 2012-12-27 CN CN201280070836.8A patent/CN104136106A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080200434A1 (en) * | 2006-09-14 | 2008-08-21 | Daniloff George Y | Chemical Target-Binding Compositions |
| US20110147308A1 (en) * | 2009-12-21 | 2011-06-23 | Siemens Water Technologies Corp. | Charged Porous Polymeric Membranes and Their Preparation |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104066497B (zh) * | 2011-12-30 | 2016-12-28 | 通用电气公司 | 具有亲水性涂层的多孔膜及其制备和使用方法 |
| CN104066497A (zh) * | 2011-12-30 | 2014-09-24 | 通用电气公司 | 具有亲水性涂层的多孔膜及其制备和使用方法 |
| CN105980846B (zh) * | 2014-02-21 | 2018-12-07 | 宝生物工程美国有限公司 | 包括聚(酸)膜分离基质的旋转柱及其制造和使用的方法 |
| CN105980846A (zh) * | 2014-02-21 | 2016-09-28 | 宝生物工程美国有限公司 | 包括聚(酸)膜分离基质的旋转柱及其制造和使用的方法 |
| CN107003306B (zh) * | 2014-11-20 | 2020-07-03 | 通用电气公司 | 具有聚合物接枝的多孔薄膜、其方法及用途 |
| CN107003306A (zh) * | 2014-11-20 | 2017-08-01 | 通用电气公司 | 具有聚合物接枝的多孔薄膜、其方法及用途 |
| CN106823864A (zh) * | 2015-12-04 | 2017-06-13 | 中国科学院大连化学物理研究所 | 一种荧光介孔膜的制备方法 |
| CN109689189A (zh) * | 2016-09-09 | 2019-04-26 | 3M创新有限公司 | 官能化共聚物及其使用 |
| CN106546729A (zh) * | 2016-10-18 | 2017-03-29 | 上海凯璟生物科技有限公司 | 一种去除干式免疫荧光定量法检测中血清基质效应的新工艺方法 |
| CN106622173A (zh) * | 2016-12-29 | 2017-05-10 | 珠海健帆生物科技股份有限公司 | Dna免疫吸附剂及其制备方法 |
| CN109395616A (zh) * | 2018-12-10 | 2019-03-01 | 天津工业大学 | 一种核孔蛋白接枝均孔聚碳酸酯仿生蛋白传输膜及其制备方法 |
| CN109395616B (zh) * | 2018-12-10 | 2021-03-09 | 天津工业大学 | 一种核孔蛋白接枝均孔聚碳酸酯仿生蛋白传输膜的制备方法 |
| CN113125708A (zh) * | 2019-12-31 | 2021-07-16 | 暨南大学 | 一种基于核孔膜的微孔板及其制备方法与应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013101855A1 (fr) | 2013-07-04 |
| EP2797680A1 (fr) | 2014-11-05 |
| EP2797680A4 (fr) | 2015-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104136106A (zh) | 具有聚合涂层的多孔膜及其制备和使用方法 | |
| CN104066497B (zh) | 具有亲水性涂层的多孔膜及其制备和使用方法 | |
| US20130171026A1 (en) | Porous membranes having a polymeric coating and methods for their preparation and use | |
| US9476876B2 (en) | Sol composition for sol-gel biochip to immobilize probe on substrate without surface treatment and method for screening thereof | |
| WO2020160472A1 (fr) | Dosage à haute sensibilité | |
| KR20000071894A (ko) | 단백질칩 및 이를 이용한 다목적 자동화 진단시스템 | |
| EP3985392A1 (fr) | Conjugué pour immunodétection basé sur un dosage à écoulement latéral, et procédé d'immunodétection l'utilisant | |
| JP2006201091A (ja) | 捕捉ビーズ用マイクロ粒子およびそれを用いた捕捉ビーズならびにバイオチップ | |
| CN107003306B (zh) | 具有聚合物接枝的多孔薄膜、其方法及用途 | |
| JPS63180857A (ja) | 診断装置、その製造方法と使用方法 | |
| US11754563B2 (en) | Porous membranes with a polymer grafting, methods and uses thereof | |
| EP1417492B1 (fr) | Laboratoire sur puce en resine photosensible pour des applications de diagnostic medical | |
| JP2005037331A (ja) | 生体由来物検出用基板及びその製造方法 | |
| US20130171618A1 (en) | Porous membranes having a polymeric coating and methods for their preparation and use | |
| US20130171368A1 (en) | Porous membranes having a polymeric coating and methods for their preparation and use | |
| JP2005181154A (ja) | 血液型抗体の測定及び／又は同定用器具並びにそれを用いた血液型抗体の測定及び／又は同定方法 | |
| JP5344438B2 (ja) | 物質固定用基板、物質固定化基板および分析方法 | |
| JP2000065832A (ja) | フィルター状生物学的特異反応測定用担体およびそれを用いた測定方法 | |
| US11014088B2 (en) | Sensitive ELISA for disease diagnosis on surface modified poly(methyl methacrylate) (PMMA) microfluidic microplates | |
| WO2021034415A9 (fr) | Méthode d'analyse basé sur un réseau assisté par concentration d'échantillon | |
| JP4706502B2 (ja) | 固相担体の製造方法 | |
| CN116819058A (zh) | 一种分析流体样本细胞外囊泡聚糖的方法及其装置和应用 | |
| JP2005283351A (ja) | 蛋白質固定化方法 | |
| CN109932513A (zh) | 呼吸道病原体检测方法 | |
| DE102009052134A1 (de) | Verfahren und Kit zur Multiplex-Detektion von Analyten in einer Probe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20170111 |
|
| AD01 | Patent right deemed abandoned |